Alfonso Duenas-Gonzalez
Alfonso Duenas-Gonzalez
Unit of Biomedical Research on Cancer, Instituto de Investigaciones Biomedicas UNAM, Instituto
Dirección de correo verificada de
Citado por
Citado por
Planning cancer control in Latin America and the Caribbean
PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ...
The Lancet Oncology 14 (5), 391-436, 2013
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin …
A Dueñas-González, JJ Zarbá, F Patel, JC Alcedo, S Beslija, L Casanova, ...
Journal of Clinical Oncology 29 (13), 1678-1685, 2011
Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors
A Duenas-Gonzalez, M Candelaria, C Perez-Plascencia, ...
Cancer treatment reviews 34 (3), 206-222, 2008
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy
B Segura-Pacheco, C Trejo-Becerril, E Perez-Cardenas, L Taja-Chayeb, ...
Clinical Cancer Research 9 (5), 1596-1603, 2003
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M Candelaria, D Gallardo-Rincón, C Arce, L Cetina, JL Aguilar-Ponce, ...
Annals of Oncology 18 (9), 1529-1538, 2007
Epigenetics of cervical cancer. An overview and therapeutic perspectives
A Dueñas-González, M Lizano, M Candelaria, L Cetina, C Arce, ...
Molecular cancer 4 (1), 1-24, 2005
OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line–specific manner
AD Gonzalez, M Kaya, W Shi, H Song, JR Testa, LZ Penn, J Filmus
The Journal of cell biology 141 (6), 1407-1414, 1998
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
P Zambrano, B Segura-Pacheco, E Perez-Cardenas, L Cetina, ...
BMC cancer 5 (1), 1-12, 2005
Ether a go-go potassium channels as human cervical cancer markers
LMB Farias, DB Ocana, L Díaz, F Larrea, E Avila-Chávez, A Cadena, ...
Cancer research 64 (19), 6996-7001, 2004
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
A Chavez-Blanco, B Segura-Pacheco, E Perez-Cardenas, L Taja-Chayeb, ...
Molecular cancer 4 (1), 1-9, 2005
Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer
A Serrano-Olvera, A Dueñas-González, D Gallardo-Rincón, M Candelaria, ...
Cancer treatment reviews 32 (3), 180-190, 2006
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer
C Arce, C Pérez-Plasencia, A González-Fierro, E de la Cruz-Hernández, ...
PloS one 1 (1), e98, 2006
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative …
RE Kast, JA Boockvar, A Brüning, F Cappello, WW Chang, B Cvek, ...
Oncotarget 4 (4), 502, 2013
A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin …
A Duenas-Gonzalez, C Lopez-Graniel, A Gonzalez-Enciso, L Cetina, ...
Annals of oncology 14 (8), 1278-1284, 2003
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
A Chavez-Blanco, C Perez-Plasencia, E Perez-Cardenas, ...
Cancer cell international 6 (1), 1-9, 2006
Modern management of locally advanced cervical carcinoma
A Dueñas-Gonzalez, L Cetina, I Mariscal, J de la Garza
Cancer treatment reviews 29 (5), 389-399, 2003
Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline
LT Chuang, S Temin, R Camacho, A Dueñas-Gonzalez, S Feldman, ...
Journal of global oncology 2 (5), 311-340, 2016
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
J Coronel, L Cetina, I Pacheco, C Trejo-Becerril, A González-Fierro, ...
Medical oncology 28 (1), 540-546, 2011
Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer
G Vazquez-Ortiz, P Pina-Sanchez, K Vazquez, A Duenas, L Taja, ...
BMC cancer 5 (1), 1-11, 2005
Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease.
A Dueñas-Gonzalez, CM Isales, M del Mar Abad-Hernandez, ...
Modern pathology: an official journal of the United States and Canadian …, 1997
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20